Retractable Technologies

Retractable Technologies (RTI) is a mission-driven medical device company focused on eliminating needlestick injuries through its proprietary automated retraction technology. Its core strategy leverages a dual value proposition of uncompromising clinician safety and tangible cost savings for healthcare systems, evidenced by adoption in eight of the top ten U.S. hospitals and the provision of billions of syringes during the COVID-19 pandemic. The company executes this strategy by manufacturing a comprehensive portfolio of safety devices, advocating for strong safety regulations, and continuously innovating its platform to expand its market reach and impact.

Proprietary automated retraction mechanism for syringes and needles, enabling passive, single-handed activation that retracts the needle into the device barrel immediately after use, combined with Low Dead Space (LDS) design to minimize medication waste.

RTI competes primarily on its superior passive retraction technology against larger firms offering active safety devices or add-on shields. Its focused expertise and validation by top U.S. hospitals are strengths, but it faces constant pricing pressure from diversified giants with extensive distribution networks.